XNCR Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Xencor Inc (XNCR) is not a strong buy at the moment for a beginner investor with a long-term strategy. The technical indicators are neutral, the options data suggests bearish sentiment, and the financial performance has significantly deteriorated. While analysts have raised price targets, the lack of recent positive news and weak financials make this stock less attractive for immediate investment.
The MACD is slightly positive at 0.0118, indicating weak bullish momentum. RSI is neutral at 40.874, and moving averages are converging, suggesting no clear trend. The stock is trading below the pivot level of 11.923, with key support at 10.9 and resistance at 12.946.
Analysts have raised price targets recently, with Barclays maintaining an Overweight rating and increasing the target to $27.
No significant trading activity from hedge funds, insiders, or Congress.
In Q4 2025, revenue dropped to $28.24M (-59.67% YoY), net income fell to -$6.65M (-87.56% YoY), and EPS declined to -0.09 (-87.67% YoY). Gross margin remained stable at 100%.
Barclays raised the price target to $27 from $26 with an Overweight rating. BofA raised the target to $20 from $17 with a Neutral rating, citing improving conditions in the biotech sector but expressing concerns about sustainability.
